SCHEMBL1243950

SCHEMBL1243950

CCC/C=C/C=C/O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12074100 1.00
SCHEMBL1243953 1.00
SCHEMBL31067751 0.97 ALDH1A1 (0.39)
SCHEMBL29285264 0.97 ALDH1A1 (0.39)
SCHEMBL31373177 0.90 PPARA (0.42)
SCHEMBL28512100 0.90 FAAH (0.41)
SCHEMBL5138654 0.90 FAAH (0.41)
SCHEMBL28671413 0.88 FASN (0.47)
SCHEMBL7290600 0.86 PPARA (0.38)
SCHEMBL731193 0.84 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361350-B2 Silver nanoparticle ink composition XEROX CORPORATION (US) 2013-01-29 US claimed
US-20100143591-A1 SILVER NANOPARTICLE INK COMPOSITION XEROX CORPORATION (US) 2010-06-10 US claimed
EP-0003708-B1 PROCESS FOR THE STEREOSELECTIVE SYNTHESIS OF SEXUAL PHEROMONES AND THE PHEROMONES SO OBTAINED Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 1981-08-19 EP claimed
US-20250057785-A1 APPLICATION OF 10'(Z), 13'(E), 15'(E)-HEPTADECATRIENYL HYDROQUINONE (HQ17(3)) IN TREATING CORONAVIRUS INFECTION NATIONAL ATOMIC RESEARCH INSTITUTE (TW) 2025-02-20 US disclosed
EP-3805190-B1 PROCESS FOR SYNTHESIZING OF HYDROQUINONE DERIVATIVES WITH HEPTADECATRIENYL SIDE CHAIN INER AEC EXECUTIVE YUAN (TW) 2023-03-29 EP disclosed
EP-3235646-B1 METHOD OF FORMING PIEZO DRIVER ELECTRODES XEROX CORP (US) 2022-03-16 EP disclosed
US-11078144-B2 Process for synthesizing of hydroquinone derivatives with heptadecatrienyl side chain Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C (TW) 2021-08-03 US disclosed
US-20210122690-A1 PROCESS FOR SYNTHESIZING OF HYDROQUINONE DERIVATIVES WITH HEPTADECATRIENYL SIDE CHAIN Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C (TW) 2021-04-29 US disclosed
EP-3805190-A1 PROCESS FOR SYNTHESIZING OF HYDROQUINONE DERIVATIVES WITH HEPTADECATRIENYL SIDE CHAIN Institute of Nuclear Energy Research Atomic Energy Council Executive Yuan, R.O.C (TW) 2021-04-14 EP disclosed
US-10675842-B2 Transparent electrode and organic electronic device including the same Konica Minolta, Inc. (JP) 2020-06-09 US disclosed
US-10305063-B2 Transparent organic electroluminescence element Konica Minolta, Inc. (JP) 2019-05-28 US disclosed
US-20070004847-A1 Emulsion composition of modified polypropylene TONEN CHEMICAL CORPORATION (JP) 2007-01-04 US disclosed
WO-2006069263-A1 USE OF SEQUENCE SPECIFIC POLYMERS IN CHEMICAL DETECTION KALINEX (US) 2006-06-29 WO disclosed
EP-1642931-A1 EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE Tonen Chemical Corporation (JP) 2006-04-05 EP disclosed
WO-2001077672-A2 MOLECULARLY IMPRINTED POLYMER BASED SENSORS FOR THE DETECTION OF NARCOTICS THE JOHNS HOPKINS UNIVERSITY (US) 2001-10-18 WO disclosed
WO-1998002406-A1 RECYCLE AND RECOVERY OF USEFUL PRODUCTS FROM HEAVY ALDOL BY-PRODUCTS EXXON CHEMICAL PATENTS, INC. (US) 1998-01-22 WO disclosed
US-5283196-A Polyacrylamide gels with improved detection of protein THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1994-02-01 US disclosed
WO-1989008100-A1 POLYACRYLAMIDE GELS FOR IMPROVED DETECTION OF PROTEINS UNITED STATES OF AMERICA, REPRESENTED BY THE SECRE (US) 1989-09-08 WO disclosed
EP-0330460-A2 Polyacrylamide gels for improved detection of proteins THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1989-08-30 EP disclosed
EP-0161877-A2 1,4-dihydropyridine derivatives, methods for their production and pharmaceutical compositions comprising the same FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) 1985-11-21 EP disclosed